EPA Moves To Integrate Cardiovascular Effects In Lead Rules’ Analyses

EPA is moving closer to accounting for adverse cardiovascular effects stemming from lead exposures into its regulatory decisions, a move that would bolster its ability to address risks that adults face from such exposures and allow the agency to advance rules that have stalled because of a lack of such data while strengthening other pending measures. “Incorporating new scientific developments into regulatory analysis is important for ensuring a well-informed policy process. The impact of lead on premature cardiovascular mortality is...